Charles river launches cliniprime suite of gmp-compliant cellular products

Wilmington, mass.--( business wire )--charles river laboratories international, inc. (nyse:crl) today announced the launch of their new cliniprimetm suite of good manufacturing practice (gmp)-compliant cellular starting materials. cliniprime products provide rapid access to starting materials for cell, and gene-modified cell therapies with a standardized production process for high-quality gmp-compliant products. all cliniprime products meet the essential regulatory guidelines for clinical trial development and the commercial manufacturing of advanced therapies.
CRL Ratings Summary
CRL Quant Ranking